Ropes & Gray partners offer Biomet regulatory counsel on Zimmer deal

The $13.35 billion merger of Biomet Inc. and Zimmer Holdings Inc. involves FCPA, IP and FDA regulatory issues

Laura G. Hoey

A deal the size the $13.35 billion merger of Biomet Inc. and Zimmer Holdings Inc. in a highly regulated industry like medical device manufacturing involves many moving parts. A team from Ropes & Gray that includes partners Laura G. Hoey and Joy J. Liu is providing regulatory counsel to Biomet. Hoey is part of the government enforcement practice at Ropes & Gray, and Liu is part of the life sciences practice.

In today’s regulatory environment, compliance is a major consideration in any medical device or pharmaceutical-related deal, according to Liu and Hoey.

Contributing Author

author image

Amy I. Stickel

Amy I. Stickel has extensive experience covering the legal, financial and pharmaceutical industries as a writer and editor. A past managing editor of Corporate Legal Times and...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.